| Korea Research Institute of Chemical Technology Patent applications |
| Patent application number | Title | Published |
|---|
| 20130123297 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS OR OBESITY COMPRISING PHENYLTETRAZOLE DERIVATIVE - A pharmaceutical composition comprising a phenyltetrazole derivative of formula (I) or a pharmaceutical acceptable salt thereof is effective in preventing or treating osteoporosis, obesity, diabetes, or hyperlipidemia, by regulating protein TAZ. | 05-16-2013 |
| 20130084329 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES - The present invention relates to a composition for external application for improving a skin disease (e.g. psoriasis). The composition contains adenosylcobalamin (coenzyme B12), optionally in admixture with other cobalamins. The composition can be present in the form of liposomal preparations, which are made of a phospholipid and cholesterol. | 04-04-2013 |
| 20130078256 | NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS - The invention is related to compounds of Formula (I): | 03-28-2013 |
| 20130065354 | Method for Manufacturing a Nanostructured Inorganic/Organic Heterojunction Solar Cell - Provided is a method for manufacturing a significantly high efficient solar cell having a novel structure and superior stability, and which can be mass-produced from an inexpensive material from an inexpensive material for enabling the easy commercial availability thereof. More particularly, the method of the present invention comprises the following step: (a) depositing slurry containing metal oxide particles and heat-treating the slurry to form a porous electron transporting layer; (b) forming inorganic semiconductors on surfaces of the metal oxide particles for the porous electron-transporting layer; and (c) impregnating the porous electron-transporting layer having the inorganic semiconductor formed thereon with a solution containing an organic photovoltaic material so as to form a hole transporting layer. | 03-14-2013 |
| 20130053390 | 1-[(6,7-SUBSTITUTED ALKOXYQUINOXALINYL)AMINOCARBONYL]-4-(HETERO)ARYLPIPERAZINE DERIVATIVES - The present invention relates to novel quinoxaline-piperazine compounds, 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives and their pharmaceutically acceptable salts, a process for their preparation thereof, and compositions containing such compounds. Therapeutic methods for the treatment of hyperproliferative disorders, including cancers, by administering quinoxaline-piperazine compounds are also included. | 02-28-2013 |
| 20130047708 | METHOD AND SYSTEM FOR MEASURING ENGINE OIL DETERIORATION - The present invention relates to a method of measuring engine oil deterioration, including measuring the first absorbance of engine oil using near infrared at a wavelength of 1000 nm or more, measuring the second absorbance of the engine oil during use using near infrared at the wavelength, and comparing the first absorbance and the second absorbance of the engine oil, so that the engine oil may be determined to be in a state of deterioration when the second absorbance may be at least 1.5 times the first absorbance, and to a system for measuring engine oil deterioration therefor. | 02-28-2013 |
| 20130036769 | HIGH-OUTPUT APPARATUS FOR MANUFACTURING A POLYCRYSTAL SILICON INGOT FOR A SOLAR CELL - The present invention relates to a high-output apparatus for manufacturing a polycrystal silicon ingot for a solar cell, and more particularly, to an apparatus for manufacturing a polycrystal silicon ingot by means of heating and melting raw silicon in a vacuum chamber, and then cooling the molten silicon, wherein the apparatus comprises: a plurality of crucibles arranged so as to be horizontally separated from one another within the vacuum chamber, and in each of which raw silicon is filled for manufacturing polycrystal silicon ingots; heating means provided at the outside of each of the crucibles so as to heat each crucible and melt the raw silicon filled therein.; and cooling means for cooling the crucibles, so as to enable the silicon melted by the heating means to be cooled in one direction and be formed into polycrystal ingots. | 02-14-2013 |
| 20130029360 | DIMERIC CORE-SHELL NANOSTRUCTURE LABELED WITH RAMAN ACTIVE MOLECULE LOCALIZED AT INTERPARTICLE JUNCTION, USE THEREOF, AND METHOD FOR PREPARING THE SAME - The present invention relates to a nanoparticle dimer in which Raman-active molecules are located at a binding portion of the nanoparticle dimer, and more particularly, to a core-shell nanoparticle dimer comprising: a gold or silver core having a surface to which oligonucleotides are bonded; and a gold or silver shell covering the core. In addition, the present invention relates to the core-shell nanoparticle dimer, to a method for preparing same, and to the use thereof. | 01-31-2013 |
| 20120322802 | NOVEL 2, 4-PYRIMIDINE DERIVATIVES AND USE THEREOF - The present invention relates to novel 2,4-pyrimidine derivatives and a use thereof, and more particularly, to pyrimidine derivatives which are effective for systemic lupus erythematosus, a composition for preventing and treating systemic lupus erythematosus comprising the same as an active ingredient and a method for screening the same. The present inventors found novel materials inhibiting surface translocation of gp96 by mimicking a function of AIMP1 which is a molecular anchor for an intracellular residence of gp96, and identified in vitro and in vivo activity of the materials for preventing and treating SLE by alleviating SLE plasma in autoimmune diseases. Therefore, the present invention provides a novel method for screening a therapeutic agent for SLE, and preventing or treating SLE using the mechanism. | 12-20-2012 |
| 20120312375 | All-Solid-State Heterojunction Solar Cell - Provided is a highly efficient solar cell having a novel structure and excellent stability, and which may be mass-produced from an inexpensive material for enabling easy commercial availability thereof. More particularly, the solar cell of the present invention comprises: a porous inorganic electron-transporting layer containing metallic oxide particles; a light absorber containing inorganic semiconductors; and an organic hole transporting layer containing an organic photo-voltaic material. | 12-13-2012 |
| 20120305082 | CONDUCTING POLYMER TO WHICH PYRENE COMPOUNDS ARE INTRODUCED, AND ORGANIC SOLAR CELL USING SAME - The present invention relates to a pyrene-containing conductive polymer represented by formula 1 and an organic solar cell comprising the same as an organic photovoltaic material. The conductive polymer has improved hole mobility as a result of introducing a specific amount of pyrene either into a polymer, which consists only of a donor functional group comprising one or more aromatic monomers, or into a donor-acceptor type polymer comprising a repeating acceptor introduced into a donor functional group. Thus, the conductive polymer can be used as an organic photovoltaic material in organic photodiodes (OPDs), organic light-emitting diodes (OLEDs), organic thin-film transistors (OTFTs), organic solar cells and the like. In addition, an organic solar cell showing high power conversion efficiency (PCE) can be provided using an organic photovoltaic material comprising the pyrene-containing conductive polymer as an electron donor. | 12-06-2012 |
| 20120214991 | Indenone Derivative and Pharmaceutical Composition Comprising Same - An indenone derivative of formula (1) is effective in enhancing the activity of osteoblastic cells and inhibiting bone resorption by osteoclastic cells, and a pharmaceutical composition comprising the indenone derivative or a pharmaceutically acceptable salt thereof is useful for preventing or treating bone diseases such as osteoporosis. | 08-23-2012 |
| 20120209001 | PIPERAZINYL-PROPYL-PYRAZOLE DERIVATIVES AS DOPAMINE D4 RECEPTOR ANTAGONISTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - The present invention relates to a novel piperazinyl-propyl-pyrazole derivative, a method of its preparation and a pharmaceutically acceptable composition comprising the same. The novel piperazinyl-propyl-pyrazole derivative of the present invention has superior selective affinity for dopamine D | 08-16-2012 |
| 20120203046 | HIGH STRENGTH SAPO-34 MICROSPHERE CATALYST, METHOD FOR PREPARING SAME, AND METHOD FOR PREPARING LIGHT OLEFINS USING SAME - The present invention relates to a high-strength silicoaluminophasphate-34 (SAPO-34) microsphere catalyst, a method for preparing the same, and a method for preparing light olefins by using the same, and when described in more detail, the present invention relates to a method for preparing a SAPO-34 microsphere catalyst, including: spray drying a mixed slurry including a matrix, a binder, an additive, and the like to a SAPO-34 slurry prepared by a hydrothermal synthesizing method using various organic templates such as tetraethylammonium hydroxide (TEAOH), and the like alone or in mixtures to prepare microspheres, and firing the microspheres, and to a SAPO-34 microsphere catalyst for a circulating-fluidized bed reactor, prepared by the preparation method. The SAPO-34 microsphere catalyst of the present invention has excellent reaction activity while having high strength, and thus is appropriate for use in a circulating-fluidized bed reactor requiring high strength of the catalyst. Further, the SAPO-34 microsphere catalyst has a long life-span and excellent conversion rate of C | 08-09-2012 |
| 20120197029 | METHOD FOR PRODUCING CYCLICISED COMPOUNDS FROM ORGANIC ACIDS HAVING FROM 4 TO 6 CARBON ATOMS - The present invention relates to a method for producing a cyclic compound that has high selectivity, high yield, and stability over a long period of time depending on a metal content ratio of a catalyst, specifically a lactone compound or a heterocyclic compound including oxygen, which includes hydrogenating an organic acid, organic acid ester, or a mixture of the organic acid and organic acid ester, which are having 4 to 6 carbon atoms, by using a selective hydrogenated catalyst. | 08-02-2012 |
| 20120187338 | (HALO)SILICATE-BASED PHOSPHOR AND MANUFACTURING METHOD OF THE SAME - Disclosed are a (halo)silicate-based phosphor and a manufacturing method of the same. More particularly, the disclosed phosphor is a novel (halo)silicate-based phosphor manufactured by using a (halo)silicate-based host material containing an alkaline earth metal, and europium as an activator. | 07-26-2012 |
| 20120184604 | COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES COMPRISING COLFORSIN DAROPATE - The present invention relates to a pharmaceutical composition for the prevention or treatment of bone diseases comprising colforsin daropate, and more particularly, the present invention relates to a pharmaceutical composition for the prevention or treatment of bone diseases such as bone fracture and osteoporosis, which inhibits osteoclast differentiation and bone resorption caused by osteoclasts and promotes osteoblast differentiation and the activity of osteoblasts, and a health functional food composition comprising colforsin daropate. | 07-19-2012 |
| 20120165183 | METHOD FOR PREPARING POROUS ORGANIC-INORGANIC HYBRID MATERIALS, POROUS ORGANIC-INORGANIC HYBRID MATERIALS OBTAINED BY THE METHOD AND CATALYTIC USES OF THE MATERIALS - The present invention relates to a method for preparing iron-containing porous organic-inorganic hybrid materials where the organic compound ligand is bonded to a central metal and has a large surface area and pores of molecular size or nano size, by irradiating microwaves instead of heat treatments such as the conventional electric heating, etc. as the heat source of the hydrothermal or solvothermal synthesis reaction, after reacting a metal or metal salt and organic compound to form crystal nuclei by a predetermined pre-treatment operation in the presence of a solvent. In another aspect, a method of the present invention further comprises the step of purifying the obtained porous organic-inorganic hybrid materials by treating them with inorganic salt. In particular, a method of the present invention is characterized by not using a hydrofluoric acid. | 06-28-2012 |
| 20120142945 | RECOVERY METHOD OF HIGHLY PURE LACTIC ACID AND ALKYL LACTATE - A method for recovery of highly pure alkyl lactate and lactic acid is provided, which includes a step 1 for producing source liquid comprising lactic acid or ammonium lactate; a step 2 for dehydrating the source liquid product of step 1; a step 3 for producing liquid mixture by sequentially adding and stirring alcohol and acid solution to the dehydrated source liquid; a step 4 for separating and removing ammonium salt precipitation from the liquid mixture of step 3; a step 5 for producing alkyl lactate from ammonium salt-free liquid mixture by esterification reaction; and a step 6 for separating alcohol and alkyl lactate by distillation from the mixture of step 5. | 06-07-2012 |
| 20120077109 | CERAMIC POROUS SUBSTRATE, REINFORCED COMPOSITE ELECTROLYTE MEMBRANE USING THE SAME AND MEMBRANE-ELECTRODE ASSEMBLY HAVING THE SAME - The present invention relates to a ceramic porous substrate, a reinforced composite electrolyte membrane using the same, and a membrane-electrode assembly having the same. The ceramic porous substrate comprises: a porous polymer base; and void structures formed on the surface of the porous polymer base by linking the space of the inorganic nanoparticles using a polymer binder or a silane-based inorganic binder. The ceramic porous substrate has improved mechanical properties compared to the porous polymer substrate alone, and the void structures thereof can be controlled in various ways. | 03-29-2012 |
| 20120065396 | ISOINDOLINONE DERIVATIVES, PREPARATION METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION COMPRISING SAME - The present invention relates to an amide compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition comprising the same. The inventive amide compound facilitates bone formation and inhibits bone loss, and is therefore useful for preventing and treating bone disorders such as osteoporosis, osteodystrophy, bone fracture, periodontal disease, Paget's disease, bone metastasis, and rheumatoid arthritis. | 03-15-2012 |
| 20120022257 | PROCESSES FOR PREPARING HIV REVERSE TRANSCRIPTASE INHIBITORS - Disclosed is a method for preparing HIV reverse transcriptase inhibitors which inhibit replication of HIV in HIV infected cells, and novel intermediate compounds used therein. | 01-26-2012 |
| 20120018715 | CONDUCTIVE POLYMER CONTAINING CARBAZOLE, AND ORGANIC PHOTOVOLTAIC DEVICE USING SAME - The present invention relates to a 2,7-carbazole-containing polymer represented by formula 1 and an organic photovoltaic device comprising the conductive polymer as a photoelectric conversion material. The conductive polymer has high photon absorption efficiency and improved hole mobility and is prepared by introducing a specific amount of a carbazole compound either into a polymer, consisting only of a donor functional group containing one or more aromatic monomers, or into a donor-acceptor type polymer comprising a repeating acceptor group introduced into a donor functional group. The conductive polymer can be used as a photoelectric conversion material for organic thin film transistors (OTFTs) or organic light-emitting diodes (OLEDs). Furthermore, the invention provides an organic photovoltaic device comprising the carbazole-containing conductive polymer as an electron donor, and thus can achieve high photoelectric conversion efficiency in organic thin film solar cells. | 01-26-2012 |
| 20120004476 | Fullerene Derivatives and Organic Electronic Device Comprising the Same - The present invention relates to fullerene derivatives and an organic electronic device using the same, and more specifically, to a novel fullerene derivative incorporating an aromatic fused ring compound and to an organic electronic device with excellent electrical properties by employing the fullerene derivative. In more detail, the novel fullerene derivative incorporating an aromatic fused ring compound according to the present invention exhibits excellent solubility in organic solvents and has a high electrochemical electron mobility and a high LUMO energy level, thereby making the fullerene derivative a suitable material for organic solar cells featuring a high open circuit voltage (Voc) and an improved energy conversion efficiency, or applicable for use in organic electronic devices such as organic thin film transistors. | 01-05-2012 |
| 20110319574 | Hexafluoropropylene Oxide Polymer Compositions and a Preparing Method of Hexafluoropropylene Oxide Polymer Using Hexafluoropropylene Oligomer - The present invention relates to hexafluoropropylene oxide polymer composition and a process of preparing of hexafluoropropylene oxide polymer by an anionic polymerization, and in particular the hexafluoropropylene oxide polymer composition comprises an anionic initiator, a polar solvent, hexafluoropropylene and hexafluoropropylene oxide. The hexafluoropropylene oxide polymer is prepared under particular reaction conditions by using the composition, hexafluoropropylene oxide polymer prepared by using the composition according to a preparation process herein has a weight average molecular weight (Mw) of 1,500-4,000 at −10-20° C. | 12-29-2011 |
| 20110318275 | MULTIFUNCTIONAL CONTRAST AGENT USING BIOCOMPATIBLE POLYMER AND PREPARATION METHOD - The present invention relates to a biocompatible contrast agent and a method of its preparation. More particularly, the present invention relates to a multifunctional contrast agent manufactured by prepairing a novel polysuccinimide-based polymer by introducing an alkanolamine group to the main group of the polysuccinimide in addition to a biocompatible hydrophilic group, which improves bioavailability, and a hydrophobic group, which enables to maintain the form of stable nanoparticles during the formation of nano particles for a long period of time and to encapsulate a hydrophobic anticancer agent. | 12-29-2011 |
| 20110262416 | Bacillus subtilis strain having antagonistic activity for controlling plant diseases - A novel strain of | 10-27-2011 |
| 20110251338 | MICHAEL ACCEPTOR HAVING MULTIPLE HYDROXYL GROUPS, AND MICHAEL ADDITION PRODUCT DERIVED THEREFROM - Provided is a Michael addition product prepared from a multifunctional acryl monomer having multiple hydroxyl groups allowing introduction of acryl functional groups, as a Michael acceptor, and a Michael donor. The Michael addition product is a novel multifunctional compound having an oligomer and a photoinitiator moiety in the molecule. Since it can be cured under a standard UV curing condition without having to add a photoinitiator, it is reduced to air pollution or health problem. Therefore the superior physical properties were obtained by cured coatings without surface tackiness. In addition, its hydroxyl groups allow, through isocyanate bonding or introduction of acryl groups, 3-dimensional crosslinking and molecular and compositional design for improving expandability, friction, and reactivity and hydrophilicity for self-adhesion, hardness of cured film, or the like. Consequently, a very useful, multifunctional or water-dispersible coating composition may be prepared. | 10-13-2011 |
| 20110245358 | HYDROGEL CONTACT LENSES HAVING IMPROVED WETTABILITY - The present invention relates to a hydrogel contact lens having improved wettability, and particularly to a hydrogel contact lens of a complex membrane having an IPN (interpenetrating polymer network) intra structure, which is prepared by crosslinking composition for a contact lens comprising, as a main ingredient, an acryl monomer and an oligosaccharide and optionally a silicone compound. Due to the presence of an oligosaccharide in a contact lens herein, tensile strength and wettability can be maximized to provide a superior wearing feeling and maintain wettability even after a long-term storage in a care solution such as a washing solution, a storage solution and a protein-removing solution. | 10-06-2011 |
| 20110239748 | QUANTITATIVE EVALUATION OF SCRATCH-INDUCED DAMAGES ON POLYMERIC AND COATING MATERIALS - Provided is a method for quantitative evaluation of mar- and scratch-induced surface damage on polymeric and coating materials. The method for quantitative evaluation of scratch-induced damage on polymeric and coating materials includes: preparing a test specimen of polymeric and coating materials; inducing a scratch damage on the surface of the test specimen; representing the scratch damage formed on the test specimen as corresponding color coordinates; and calculating a quantitated scratch damage index from a combination of a load applied to the surface of the test specimen and the color coordinates corresponding to the scratch damage. | 10-06-2011 |
| 20110237587 | 1,3,5-Triazine-2,4,6-Triamine Compound or Pharmaceutical Acceptable Salt Thereof, and Pharmaceutical Composition Comprising the Same - Disclosed herein are a 1,3,5-triazine-2,4,6-triamine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a composition for preventing or treating metabolic syndromes, diabetes, or cancers with deletion of P53 gene, which comprises the same. | 09-29-2011 |
| 20110236298 | Adsorbent for Water Adsorption and Desorption - The present invention relates to methods for absorbing and/or desorbing water by contacting water with hybrid inorganic-organic material having high surface area, and pores with the size of molecules or nanometers. More specifically, the water adsorbent has facile adsorption-desorption even below 100° C., having high adsorption capacity, and having high desorption capacity when it is heated up to the temperature below 100° C. The adsorbent of the present invention can be applied to a humidifier, dehumidifier, cooler and heater. The present invention also relates to a technology to control humidity using the adsorbent. | 09-29-2011 |
| 20110224083 | URACIL COMPOUNDS AND A HERBICIDE COMPRISING THE SAME - Disclosed are uracil compounds represented by Formula 1, a method for preparing the compounds, and a herbicide including the same as an active ingredient: | 09-15-2011 |
| 20110207810 | N1-BENZO[1,3]DIOXOL-5-YLMETHYL-N2-SUBSTITUTED BIGUANIDE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME - The present invention provides an N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative of formula (I) or a pharmaceutically acceptable salt thereof, a method for preparing same, and a pharmaceutical composition comprising same as an active ingredient. The inventive N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative exhibits improved blood glucose level- and lipid level-lowering effects even with a reduced dosage as compared to conventional drugs, and thus, it is useful for preventing or treating diabetes, metabolic syndromes such as insulin-independent diabetes, obesity and atherosclerosis, or a P53 gene defect-related cancer. | 08-25-2011 |
| 20110196015 | N 1-2-THIOPHENE-2-YLETHYL-N2-SUBSTITUTED BIGUANIDE DERIVATE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENTS - The present invention provides an N1-2-thiophen-2-ylethyl-N2-substituted biguanide derivative of formula (I) or a pharmaceutically acceptable salt thereof, a method for preparing same, and a pharmaceutical composition comprising same as an active ingredient. The inventive N1-2-thiophen-2-ylethyl-N2-substituted biguanide derivative exhibits improved blood glucose level- and lipid level-lowering effects even with a reduced dosage as compared to conventional drugs, and thus, it is useful for preventing or treating diabetes, metabolic syndromes such as insulin-independent diabetes, obesity and atherosclerosis, or a P53 gene defect-related cancer. | 08-11-2011 |
| 20110184029 | PYRIDONE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS - The present invention relates to 2-pyridone derivatives of Formula I or IV | 07-28-2011 |
| 20110180972 | METHOD FOR MANUFACTURING UNIFORMLY SEPARATED NANOFILAMENTS OR MICROFIBERS - Method for manufacturing uniformly separated, nanofibers, nanofilaments or microfibers. In some embodiments, the method includes steps of preparing a spinning or molten solution with a electrospinning raw material, electrospinning the solution to manufacture nanofibers, collecting the nanofibers, stretching the nanofibers, and heat-treating the collected nanofibers for a prescribed period of time. Nanofibers having a diameter of 1000 nm or less and microfibers having a diameter of 1 to 5 μm can be manufactured by methods of the invention. | 07-28-2011 |
| 20110178186 | Preparation Methods for Liquid Hydrocarbons by Fischer-Tropsch Synthesis Through Slurry Reaction - The present invention relates to a method for preparing liquid hydrocarbons via a slurry phase Fischer-Tropsch (F-T) synthesis. In particular, the present invention relates to a method for preparing liquid hydrocarbons from syngas via slurry phase F-T synthesis using a catalyst, which can prevent the decrease in catalyst activity and filter clogging due to catalyst aggrega-tion, simultaneously with improving selectivity for C | 07-21-2011 |
| 20110160386 | POLYMERIZATION OF PHENOLIC COMPOUND USING COPRINUS CINEREUS PEROXIDASE - The present invention relates to a process for preparing phenolic polymers utilizing | 06-30-2011 |
| 20110118229 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - The present invention provides a 2-arylmethylazetidine-carbapenem-3-carboxylic acid ester derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The 2-arylmethylazetidine-carbapenem-3-carboxylic acid ester derivatives or their pharmaceutically acceptable salts show high oral absorption rate, and thus can be orally administered. The active metabolites thereof have a broad spectrum of antibacterial activities against Gram-positive and Gram-negative bacteria and excellent antibacterial activities against methicillin-resistant | 05-19-2011 |
| 20110039688 | CATALYST FOR CATALYTIC CRACKING OF HYDROCARBON, WHICH IS USED IN PRODUCTION OF LIGHT OLEFIN AND PRODUCTION METHOD THEREOF - (The present invention relates to a catalyst used in the production of light olefin through catalytic cracking of naphtha in a severe condition of high temperatures and high humidity. More particularly, this invention relates to a catalyst for catalytic cracking of hydrocarbon, which is used in production of light olefin and a production method thereof, wherein the catalyst is prepared by spray-drying and firing slurry mixed so that 0.01-5.0 wt % of MnO: and 1-15 wt % of P | 02-17-2011 |
| 20110028574 | Method and Apparatus for the Continuous Separation and Discharge of Solid Catalysts and Products for Fischer-Tropsch Synthesis Reactions - The present invention relates to a continuous separation and discharge apparatus and method of solid catalysts and liquid products for Fischer-Tropsch synthesis reactions, and more particularly, to a continuous separation and discharge apparatus and method of solid catalysts and products for Fischer-Tropsch synthesis reactions involving the conversion of synthetic gas into synthetic oil, by which products of the Fischer-Tropsch synthesis including wax, as a long-chain hydrocarbon, can be stably obtained by continuously separating the products from a slurry comprising solid catalyst particles and the products using periodic pulses of a feeding gas and discharging the products through a lower portion of a reactor. Provided is a continuous separation and discharge apparatus of solid catalysts and products for Fischer-Tropsch synthesis reactions including: a level sensing device which is installed at an upper portion of a reactor and detects the slurry-level of reactants; a solid catalyst/product separation device and a discharge device which are installed at a lower portion of the reactor and separate and discharge liquid products from a mixed slurry in the reactor; and a control unit which receives a signal from the level sensing device to open and close the discharge device, wherein the separation device filters the solid catalysts, and the discharge device continuously discharges the products separated from the solid catalysts through the lower portion of the reactor by the amount of the synthesized products measured by a level sensing device. | 02-03-2011 |
| 20110015062 | COBALT/ZIRCONIUM-PHOSPHORUS/SILICA CATALYST FOR FISCHER-TROPSCH SYNTHESIS AND METHOD OF PREPARING THE SAME - The present invention relates to a cobalt/zirconium-phosphorus/silica catalyst in which cobalt, as an active ingredient, is impregnated on a zirconium-phosphorus/silica support prepared by treating the surface of silica with zirconium and phosphorus, and a method of preparing the catalyst. The catalyst has excellent reactivity since it has excellent heat and mass transfer properties due to a large pore structure of silica and increased reducibility of cobalt; excellent dispersion of cobalt and other activation substances during Fischer-Tropsch (F-T) reaction; and reduced sintering of cobalt particles during the reaction, and thus high CO conversion and stable selectivity for liquid hydrocarbon can be obtained during the F-T reaction. | 01-20-2011 |
| 20100305324 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS OR OBESITY COMPRISING PHENYLTETRAZOLE DERIVATIVE - A phamaceutical composition comprising a phenyltetrazole derivative of formula (I) or a pharmaceutical acceptable salt thereof is effective in preventing or treating osteoporosis, obesity, diabetes, or hyperlipidemia, by regulating protein TAZ. | 12-02-2010 |
| 20100298578 | Catalyst For Direct Conversion Of Esters Of Lactic Acid To Lactide And The Method For Producing Lactide Using The Same - The present disclosure discloses a catalyst for directly producing a lactide which is a cyclic ester used as a monomer for polylactides, and a method for directly producing a lactide using the catalyst, the method including the transesterification reaction between two molecules of an ester of lactic acid or a mixture containing the ester of lactic acid with a small amount of lactic acid and oligomer of lactic acid under an inert environment in the presence of a titanium-based catalyst or a catalyst mixture containing the titanium-based catalyst so as to produce lactide while simultaneously removing an alcohol (ROH) generated as a by-product. As compared to a conventional commercialized process, since the method for producing a lactide in accordance with the present disclosure is a novel process capable of directly producing the lactide from the ester of lactic acid, energy consumption is low and the lactide can be produced through a simple process showing a high yield while maintaining optical property (D-form or L-form optical isomer). | 11-25-2010 |
| 20100260661 | PREPARATION METHOD OF CHALCOPYRITE-TYPE COMPOUNDS WITH MICROWAVE IRRADIATION - A method for preparing a chalcopyrite-type semiconductor compound which is widely used as a sunlight-absorbing material. More specifically, disclosed is a method for preparing a chalcopyrite-type compound, in which microwaves are used as heat sources in the preparation of the chalcopyrite-type compound, and the chalcopyrite-type compound can be produced in a large amount in a short reaction time using a batch or continuous reactor. | 10-14-2010 |
| 20100237520 | PREPARATION OF MICROCAPSULE WITH DOUBLE LAYERED STRUCTURE - The present invention relates to a method of preparing a microcapsule with a double-layered structure which comprises the steps of performing an interfacial polymerization of an amine-aldehyde prepolymer on droplets containing an inorganic metal precursor selected from carboxylate and alkoxide compounds, and hydrolyzing the including inorganic precursors for formation of inorganic inner layer. The method of the present invention can prepare a microcapsule with a double-layered structure of an inorganic inner layer and a polymer outer layer, which is effective for eluting and substituting a core material inside the capsule. | 09-23-2010 |
| 20100145054 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME - The present invention is directed to a novel imidazole derivative having an aryl piperidine substituent of formula (I) and a method for preparation thereof, and a pharmaceutical composition containing said imidazole derivative as an active ingredient for preventing or treating a MCH (melanine-concentrating hormone)-related disease. | 06-10-2010 |
| 20100145043 | 2,4-Disubstituted-5-Aminocarbonyl-1,3-Thiazole Derivatives For Therapeutic Agent Of Antiinflammatory Disease, Method Thereof For Preparation, Therapeutic Agent For Antiinflammatory Disease Induced By SPC Activity Containing The Same - Disclosed herein are 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives, a preparation method thereof, and a therapeutic agent for treating inflammatory diseases induced by SPC, which contains the derivative as an active ingredient. The anti-inflammatory effect of the 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives was analyzed through a test employing human dermal cells and an animal test using mice and, as a result, it was found that the derivatives showed excellent inhibitory activity on SPC receptor compared to thiazole derivatives known in the prior art. Thus, the 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives or pharmaceutically acceptable salts thereof are useful as active ingredients in therapeutic agents for treating inflammatory diseases, such as inflammation, pruritus and skin infection, which appear in atopic dermatitis and other diseases induced by SPC activity. | 06-10-2010 |
| 20100144712 | TRIAZOLE DERIVATIVES HAVING ANTIFUNGAL ACTIVITY, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - A triazole derivative of formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof is superior to the conventional antifungal drugs in antifungal activity against a wide spectrum of pathogenic fungi, and has advantageously low toxicity. | 06-10-2010 |
| 20100130646 | METHOD FOR MANUFACTURING EPOXY NANOCOMPOSITE MATERIAL CONTAINING VAPOR-GROWN CARBON NANOFIBERS AND ITS PRODUCTS THEREBY - Disclosed is a method for producing an epoxy nanocomposite material containing vapor-grown carbon nanofibers and an epoxy nanocomposite material produced thereby. The method comprises physically mixing 0.1-5.0 parts by weight of vapor-grown carbon nanofibers as reinforcing materials with 100 parts by weight of an epoxy matrix resin to disperse the carbon nanofibers in the epoxy matrix resin, adding a curing agent to the mixture, and curing the mixture. According to the disclosed method, the vapor-grown carbon nanofibers are physically mixed with an epoxy matrix resin without using any solvent. Thus, the vapor-grown carbon nanofibers are sufficiently dispersed in the epoxy matrix resin compared to the case of using a solvent. Therefore, it is possible to produce an epoxy nanocomposite material having excellent mechanical strength and low friction/wear properties at room temperature and excellent thermal properties even at high temperature. Also, the vapor-grown carbon nanofibers are cost-effective and, at the same time, used in an amount smaller than the amount of carbon nanotubes used to improve the physical properties of epoxy resin in the prior art, thus effectively reducing the production cost of the nanocomposite material. | 05-27-2010 |
| 20100130349 | PREPARING PHOSPHORUS CONTAINING ALUMINA SUPPORT BY SOL-GEL METHOD FOR FISCHER-TROPSCH SYNTHESIS AND CATALYST PREPARATION THEREOF - The present invention relates to a process of preparing of a phosphorus-containing phosphorus-alumina support by a sol-gel method and a cobalt/phosphorus-alumina catalyst where cobalt is supported onto the phosphorus-alumina support as an active ingredient. The phosphorus-alumina support is prepared by a sol-gel method and has wide specific surface area with bimodal pore size distribution and high cobalt dispersion, thereby enabling to increase heat and mass transfer, stabilize the structure by modifying the surface property of alumina and decrease the deactivation rate due to the reduced oxidation of cobalt component during the F-T reaction. When Fischer-Tropsch reaction (F-T) is conducted on the catalyst, the catalyst maintains a superior thermal stability, inhibits the deactivation due to water generation during the F-T reaction and also causes relatively high conversion of carbon monoxide and stable selectivity of liquid hydrocarbons. | 05-27-2010 |
| 20100113843 | PROCESS OF PRODUCING MONOHYDRIC ALCOHOLS FROM MONOCARBOXYLIC ACIDS OR DERIVATIVES THEREOF - Disclosed herein is a method for producing monohydric alcohols from monocarboxylic acids or derivatives thereof using a catalyst comprising ruthenium (Ru) and tin (Sn) using zinc oxide (ZnO) as both a catalyst support and an active promoter; a catalyst prepared by adding an inorganic binder such as silica, alumina or titania in a limited range to the catalyst comprising the above components in order to impart a shaping ability to the catalyst; or, a modified catalyst reformed by adding at least one reducing component selected from the group consisting of Co, Ni, Cu, Ag, Rh, Pd, Re, Ir, and Pt to the catalyst in order to improve the reducing ability of the catalyst. By using such catalysts, the method according to the present invention is advantageous in that the monohydric alcohols can be prepared in high yield regardless of whether the monocarboxylic acids contain water or not, the monohydric alcohols can be economically prepared because the catalysts can be operated under mild reaction conditions and also exhibits high selectivity and productivity compared to conventional catalysts, and the catalysts have excellent long-term reaction stability so as to be advantageous for industrial applications. | 05-06-2010 |
| 20100105704 | 7-(3',4'-Dialkoxyphenyl)-[1,2,4]-Triazolo[1,5-A]Pyrimidine Compounds, Process for Preparing Thereof, and Pharmaceutical Composition for Treating or Preventing Asthma, Chronic Obstructive Pulmonary Disease, Arthritis, Atopic Dermatitis, Tumor and Degenerative Brain Diseases Comprising the Same - The present invention relates to novel {7-(3′,4′-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds or pharmaceutically acceptable salts thereof, a process for preparing the same, and pharmaceutical compositions for treating or preventing inflammatory diseases including asthma and chronic obstructive pulmonary disease, arthritis, atopic dermatitis, cancers including leukemia, and degenerative brain diseases including Alzheimer's disease, depression and memory impairment, which comprises the same as an active ingredient. | 04-29-2010 |
| 20100101569 | AUTOMATIC VIDEO INSTILLATOR - An automatic video instillator that can accurately and easily administer inhalation into an airway of an animal by providing images of a throat is provided. An automatic video instillator includes a case defining a space, a guide unit that protrudes frontward from the case to secure an airway of an animal by being inserted through a throat of the animal, an image pickup unit that is installed on a front end of the guide unit to capture images of portions in front of the guide unit, an administration unit that is installed through the case and the guide unit to administer an inhalation, an administration switch for adjusting administration of a predetermined amount of the inhalation directed to the administration unit into the airway of the animal, and an image display unit that is connected to the image pickup unit to allow a user to see the images captured by the image pickup unit. | 04-29-2010 |
| 20100093523 | CATALYSTS FOR FISCHER-TROPSCH SYNTHESIS ON COBALT/PHOSPHORUS-ALUMINUM OXIDE AND PREPARATION METHODS THEREOF - The present invention relates to a cobalt/phosphorus-alumina catalyst in which cobalt is supported as an active component on a phosphorus-alumina support wherein phosphorus is supported on alumina surface. With a bimodal pore structure of pores of relatively different pore sizes, the catalyst provides superior heat- and matter-transfer performance and excellent catalytic reactivity. Especially, when Fischer-Tropsch (F-T) reaction is performed using the catalyst, deactivation by the water produced during the F-T reaction is inhibited and, at the same time, the dispersion and reducing property of cobalt and other active component are improved. Therefore, the cobalt/phosphorus-alumina catalyst for F-T reaction in accordance with the present invention provides good carbon monoxide conversion and stable selectivity for liquid hydrocarbons. | 04-15-2010 |
| 20100069630 | NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell proliferation. | 03-18-2010 |
| 20100063317 | METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES - Optically active 2-sulfonyloxy-1-phenylethanol derivative of formula (II) can be prepared easily and selectively by the method of the present invention using an asymmetric reduction of an α-sulfonyloxy acetophenone compound with a rhodium catalyst having petamethylcyclopentadienyl group and a hydrogen donor, and the compound of formula (II) obtained in the inventive method exhibits a higher e.e. (enantiomer excess) value than that of the products in the conventional methods. | 03-11-2010 |
| 20100063286 | PIPERAZINYL-PROPYL-PYRAZOLE DERIVATIVES AS DOPAMINE D4 RECEPTOR ANTAGONISTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - The present invention relates to a novel piperazinyl-propyl-pyrazole derivative, a method of its preparation and a pharmaceutically acceptable composition comprising the same. The novel piperazinyl-propyl-pyrazole derivative of the present invention has superior selective affinity for dopamine D4 receptor, can effectively inhibit psychotic behavior (cage climbing) induced by apomorphine, and has relatively low adverse effects in mouse rotarod test. Therefore, it can be developed as a therapeutic agent for the treatment and prevention of central nervous system (CNS) disorders, in particular, schizophrenia, attention deficit hyperactivity disorder, depression, stress diseases, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, cognitive disorder, Alzheimer's disease, Parkinson's disease, anxiety, paraphrenia, mania, seizure disorder, personality disorder, migraine, drug addiction, alcohol addiction, obesity, eating disorder, and sleeping disorder. | 03-11-2010 |
| 20100063106 | AMINOPYRAZOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC DISEASES CONTAINING THE SAME - Provided are aminopyrazole derivatives, a process for the preparation thereof, and a composition for preventing or treating an ischemic disease containing the same. Since the aminopyrazole derivatives of the present invention can reduce an ischemic cell death significantly, they can be effectively used for the prevention and treatment of ischemic diseases mediated by ischemic cell death, or protection of organs. | 03-11-2010 |
| 20100048570 | THIAZOLIDINE DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF - The present invention relates to novel 2-carbonyl-3-acyl-1,3-thiazolidines having a β-amino group on the acyl chain, in free, prodrug form or pharmaceutically acceptable salt thereof, including their enantiomers, diastereomers and racemates, as efficient inhibitors against DPP-IV. The invention further relates to the pharmaceutical compositions comprising the disclosed compounds. The present invention also relates to methods for preparing the disclosed compounds and for treating DPP-IV-mediated diseases. | 02-25-2010 |
| 20100044679 | Method For Producing Carbon Nanotube Transistor And Carbon Nanotube Transistor Thereby - The present invention relates to a method of manufacturing a carbon nanotube transistor in which a carbon nanotube channel is formed between a source electrode and a drain electrode and a gate electrode is formed at one side of the carbon nanotube channel, the method comprising the steps of: (a) forming the carbon nanotube channel on a substrate; (b) electrically connecting the source electrode and the drain electrode to both ends of the carbon nanotube channel, respectively; and (c) applying a stress voltage across the source electrode and the drain electrode to remove metallicity of the carbon nanotube channel. | 02-25-2010 |
| 20100043636 | POROUS NANOHYBRID MATERIALS FORMED BY COVALENT HYBRIDIZATION BETWEEN METAL-ORGANIC FRAMEWORKS AND GIGANTIC MESOPOROUS MATERIALS - Disclosed herein is a nanoporous hybrids formed by covalent bonding between a crystalline organic-inorganic hybrid and a gigantic mesoporous metal oxide, containing organic groups on the surface thereof, having a size of 10 nm or more. Since the covalently-bonded hybrid nanoporous composite has a large surface area, a multiple microporous structure, a large pore volume and includes an organic-inorganic hybrid having backbone flexibility, the covalently-bonded hybrid nanoporous composite can be used as materials for storing liquids and gases, such as hydrogen, methane and the like, and can be used as adsorbents, separating materials, catalysts, and the like. Further, the covalently-bonded hybrid nanoporous hybrids can be used in the application fields of biomolecule supporting, drug delivery, harmful material removal, nanoparticle supporter, sensors, catalysis, adsorbents, fluorescent materials, solar cells, and the like. | 02-25-2010 |
| 20100040660 | DEVELOPMENT OF A TISSUE - ENGINEERED SCAFFOLD FOR NERVE REGENERATION USING A BIOCOMPATIBLE AND INJECTABLE HYDROGEL - The present invention relates to a tissue-engineered scaffold prepared by using a biocompatible and injectable hydrogel, and particularly to a tissue-engineered scaffold capable of regenerating or recovering an injured spinal nerve for central nervous system after being implanted to connect neurons, prepared by combining an adult stem cell or a nerve cell with a physiologically active material on tissue-engineered carriers comprising biocompatible and temperature-sensitive polyethylene glycol/polyester block copolymer or biocompatible and injectable hydrogel made of small intestinal submucosa tissue powder with sol-gel phase transition behavior. | 02-18-2010 |
| 20100037345 | Polypeptide having Methionine Synthesis Function, Polynucleotide Encoding the Polypeptide, and Those Use - Disclosed herein are a polypeptide having a methionine synthesis function, a polynucleotide encoding the same, and uses thereof. | 02-11-2010 |
| 20100035866 | NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIAZIN-3ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - The present invention relates to compounds of substituted-1,1-dioxo-benzo[1,2,4]thiadiazin-3-ones acting as a 5HT6 receptor antagonist, a preparation method thereof, and a pharmaceutical composition containing the same for treatment of the central nervous system disorders. The compounds of substituted-1,1-dioxo-benzo[1,2,4]thiadiazin-3-ones according to the present invention have excellent binding affinity for the 5HT6 receptor and excellent selectivity for the 5HT6 receptor over other receptors. Also, the compounds reverse a disruption of PPI by apomorphine and don't show rotatod deficit in mice. Therefore the compounds according to the present invention may be valuably used for treatment of a 5HT6 receptor relating disorders. | 02-11-2010 |
| 20100034827 | NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS - The invention is related to compounds of Formula (I), (II), or (III); or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds. | 02-11-2010 |
| 20100021732 | FILAMENT BUNDLE TYPE NANO FIBER AND MANUFACTURING METHOD THEREOF - A filament type nano-sized lone fiber and a method of producing the same are disclosed. In the method, a spinning solution or a spinning melt is electro-spun in drops using a spinneret to which a critical voltage is applied, and the spun drops are continuously collected on a multi-collector. The spinning solution is produced dissolving a blend or copolymer consisting of two or more kinds of polymers in a solvent. The spinning melt is produced by melting the polymers. The multi-collector is selected from the group consisting of a plate type collector, a roll type collector, and a combination thereof. The filament type nano-sized long fiber is processed into a yarn through one step during the electrospinning process, and thus, mechanical properties are better than those of conventional nanofiber non-woven fabric. Consequently, the filament type nano-sized long fiber can be utilized for the extended application. | 01-28-2010 |
| 20090291044 | ANATASE TYPE TiO2 NANORODS AND ITS PREPARATION METHOD - Provided is a process which includes slowly adding dropwise chilled distilled water to titanium tetrachloride to prepare solution of titanium oxychloride; adding basic solution thereto to maintain pH of the titanium oxychloride solution within a range from 3.5 to 4, thereby providing a suspension of titanium oxyhydroxide precipitate; adding basic solution thereto to adjust the suspension of titanium oxyhydroxide precipitate to be weakly basic, and heating and stirring the mixture at 80 to 100° C.; isolating and collecting dihydroxy-oxotitanium from the heated and stirred suspension of titanium oxyhydroxide precipitate, and washing it with weakly basic aqueous solution; and adding distilled water and 20 to 500 folds of hydrogen peroxide on the basis of 1 mole of Ti | 11-26-2009 |
| 20090275770 | NOVEL TIN AMINO-ALKOXIDE COMPLEXES AND PROCESS FOR PREPARING THEREOF - The present invention relates to novel tin amino-alkoxide complexes and a method for preparing the same, precisely novel tin amino-alkoxide complexes represented by formula 1 and useful as a precursor for tin and tin oxide thin films and a precursor for the production of nano-sized tin and tin oxide particles and a method for preparing the same. In formula 1, A is linear or branched (C2-C10) alkylene substituted or not substituted with halogen; R | 11-05-2009 |
| 20090263621 | POROUS ORGANIC-INORGANIC HYBRID MATERIALS AND ADSORBENT COMPRISING THE SAME - The present invention relates to an adsorbent using the porous organic-inorganic hybrid material(s) containing iron having a large surface area and a high pore volume, in particular, a water adsorbent. Also, it relates to an adsorbent that can be used in humidifiers, dehumidifiers, coolers/heaters, a refrigerating machine or an air conditioner, etc., which can easily absorb or desorb at 100° C. and below, and has a great adsorption amount per weight of the adsorbent. | 10-22-2009 |
| 20090258876 | NOVEL INDOL CARBOXYLIC ACID BISPYRIDYL CARBOXAMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD AND COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT - Disclosed herein are a new indole carboxylic acid bispyridyl carboxamide derivative, a preparation method thereof, and a composition for prevention or treatment of obesity, urinary disorders, and CNS disorders, containing the same as an active ingredient. Because the indole carboxylic acid bispyridyl carboxamide derivatives according to the present invention have high affinity for 5-HT | 10-15-2009 |
| 20090203708 | NOVEL SUBSTITUTED-1-H-QUINAZOLINE-2,4-DIONE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - Disclosed herein are novel substituted-1H-quinazoline-2,4-dione derivatives, a preparation method thereof, and a pharmaceutical composition containing the same. The novel substituted-1H-quinazoline-2,4-dione derivatives are excellent in binding affinity and selectivity for 5-HT6 receptors over other receptors, inhibit serotonin(5-HT)-stimulated cAMP accumulation, and disrupt apomorphine(2 mg/kg, i.p.)-induced hyperactivity in rats. Thanks to these effects, the derivatives are useful in the treatment of 5-HT6 receptor-related central nervous system diseases. | 08-13-2009 |
| 20090131703 | Preparation Method of Porous Organic Inorganic Hybrid Materials - The present invention relates to a synthesis method of porous hybrid inorganic-organic materials that can be applied for adsorbents, gas storages, sensors, membranes, functional thin films, catalysts, catalyst supports, encapsulating guest molecules and separation of molecules by the pore structures. More specifically, the present invention relates to the synthesis method of nanocrystalline porous hybrid inorganic-organic materials. | 05-21-2009 |
| 20090130411 | Adsorbent for Water Adsorption and Desorption - The present invention relates to an adsorbent obtained by using porous hybrid inorganic-organic materials that have high surface area, and have pore with the size of molecules or nanometers. More specifically, the present invention relates to a water adsorbent showing facile adsorption-desorption even below 100° C., having high adsorption capacity, and having high desorption capacity when it is heated up to the temperature below 100° C. The adsorbent of the present invention can be applied to a humidifier, dehumidifier, cooler and heater. The present invention also relates to a technology to control humidity using the adsorbent. | 05-21-2009 |
| 20090117380 | Filament Bundle Type Nano Fiber and Manufacturing Method Thereof - A filament type nano-sized long fiber and a method of producing the same. In the method, a spinning solution or a spinning melt is electro-spun in drops using a spinneret to which a critical voltage is applied, and the spun drops are continuously collected on a multi-collector. The spinning solution is produced by dissolving a blend or copolymer consisting of two or more kinds of polymers in a solvent. The spinning melt is produced by melting the polymers. The multi-collector is selected from the group consisting of a plate type collector, a roll type collector, and a combination thereof. The filament type nano-sized long fiber is processed into a yarn through one step during the electrospinning process, and thus, mechanical properties are better than those of a conventional nanofiber non-woven fabric. Consequently, the filament type nano-sized long fiber can be utilized for the extended application. | 05-07-2009 |
| 20090112035 | SOLID ACID CATALYST FOR PRODUCING LIGHT OLEFINS AND PROCESS USING THE SAME - A porous solid acid catalyst for producing light olefins is prepared through pillaring and a solid state reaction of a raw material mixture. The catalyst is made of a porous material having a crystalline structure that is different from that of the raw material mixture. The catalyst exhibits excellent catalytic activity (i.e., conversion and selectivity) in the production of light olefins from hydrocarbon feeds such as full range naphthas. | 04-30-2009 |
| 20090072196 | RED PHOSPHOR AND METHOD OF PREPARING THE SAME - Provided is a red phosphor which is excellent in emission efficiency by a long wavelength UV excitation source and has a fine and uniform particle size. The red phosphor includes a compound represented by (Li.sub.(2−z)−xM.sub.x)(AO.sub.4).sub.y:Eu.sub.z,Sm.sub.q and a flux wherein M is K, Mg, Na, Ca, Sr, or Ba, A is Mo or W, 0.ltoreq.x.ltoreq.2, 0.5.ltoreq.y.ltoreq.5, 0.01.ltoreq.z.ltoreq.1.5, and 0.001.ltoreq.q.ltoreq.1.0. Provided is also a method of preparing the red phosphor. | 03-19-2009 |
| 20090042872 | Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same - Disclosed herein are rhodanine derivatives, a method for the preparation thereof, and a pharmaceutical composition containing the same. The rhodanine derivatives have inhibitory activity against protein phosphatases (PPase) such as PTP1B, Prl-3, LAR, CD45, Cdc25A, Cdc25B, Cdc25C, Yop, PP1 and VHR, and can be applied for the prevention and treatment of PPase-caused diseases, including autoimmune diseases, diabetes, impaired glucose intolerance, insulin resistance, obesity, cancers, etc. when the inhibitory activity thereof is modulated. | 02-12-2009 |
| 20090023010 | METHOD OF SURFACE MODIFICATION OF POLYIMIDE FILM USING ETHYLENEIMINES COUPLING AGENT, MANUFACTURING METHOD OF FLEXIBLE COPPER CLAD LAMINATE AND ITS PRODUCT THEREBY - A method of surface modifying a polyimide film, a method of manufacturing a flexible copper clad laminate using the same, and a flexible copper clad laminate (FCCL) having a two-layer structure manufactured thereby. The method of surface modifying a polyimide film is conducted by modifying the surface of a polyimide film through a first plasma treatment, dipping the polyimide film into a solution containing an ethyleneimine-based silane coupling agent prepared by mixing the compound of Formula 1 and the compound of Formula 2 at a molar ratio of with 0.25˜1, and then modifying the surface of the polyimide film through a second plasma treatment. The method of surface modifying a polyimide film is advantageous because it may be substituted for a conventional surface treatment processes using ion beams. Also, the FCCL having a two-layer structure, formed by conducting copper sputtering and electroplating on the surface modified polyimide film, has good adhesive strength between the polyimide film and the copper foil and can maintain such adhesive strength even at high temperatures for a long period of time. Further, it may be usefully applied to electronic parts, such as flexible printed circuit boards, TCP (Tape Carrier Package), COF (Chip On Film), etc. | 01-22-2009 |
| 20080318963 | 1-[6,7-Substituted Alkoxyquinoxalinyl) Aminocarbonyl]-4-(Hetero) Arylpiperazine Derivatives - The present invention relates to novel quinoxaline-piperazine compounds, 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives and their pharmaceutically acceptable salts, a process for their preparation thereof, and compositions containing such compounds. Therapeutic methods for the treatment of hyperproliferative disorders, including cancers, by administering quinoxalin-piperazine compounds are also included. | 12-25-2008 |
| 20080280901 | Pharmaceutical Composition for Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyacrylate Derivatives - The present invention relates to a use of a specific alpha-arylmethoxyacrylate derivative, or its pharmacologically acceptable salt or solvate for preventing and treating metabolic bone diseases. | 11-13-2008 |
| 20080275058 | N-Substituted-1H-Quinoline-2,4-Diones, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same - The present invention relates to compounds of N-substituted -1H-quinoline-2,4-diones acting as a 5HT6 receptor antagonist, a preparation method thereof, and a pharmaceutical composition containing the same for treatment of the central nervous system disorders. The compounds of N-substituted-1H-quinoline-2,4-diones according to the present invention have excellent binding affinity for the 5HT6 receptor and excellent selectivity for the 5HT6 receptor over other receptors. Also, the compounds reverse a disruption of PPI by methamphetamine and don't show rotatod deficit in mice. Thereof the compounds according to the present invention may be valuably used for treatment if a 5HT6 receptor relating disorder | 11-06-2008 |
| 20080241538 | Filament Bundle Type Nano Fiber and Manufacturing Method Thereof - A filament type nano-sized long fiber and a method of producing the same are disclosed. In the method, a spinning solution or a spinning melt is electro-spun in drops using a spinneret to which a critical voltage is applied, and the spun drops are continuously collected on a multi-collector. The spinning solution is produced by dissolving a blend or copolymer consisting of two or more kinds of polymers in a solvent. The spinning melt is produced by melting the polymers. The multi-collector is selected from the group consisting of a plate type collector, a roll type collector, and a combination thereof. The filament type nano-sized long fiber is processed into a yarn through one step during the electrospinning process, and thus, mechanical properties are better than those of a conventional nanofiber non-woven fabric. Consequently, the filament type nano-sized long fiber can be utilized for the extended application. | 10-02-2008 |
